Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT00006243Not ApplicableCompleted
Vaccine Therapy and Sargramostim in Treating Patients With Stage IV Malignant Melanoma
Recurrent MelanomaStage IV Melanoma
Principalinvestigator
NCT00024011Phase 2Completed
PS-341 in Treating Patients With Metastatic Malignant Melanoma
Recurrent MelanomaStage IV Melanoma
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Mayo Clinic

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Paul Chapman

Memorial Sloan Kettering Cancer Center

Moderately Similar
3 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV MelanomaStage IV Skin Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Thomas Gajewski

University of Chicago Comprehensive Cancer Center

Moderately Similar
3 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV MelanomaStage IV Skin Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Joseph Skitzki

Roswell Park Cancer Institute

Related
3 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV Skin Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Muralidhar Beeram

Cancer Therapy and Research Center at The UT Health Science Center at San Antonio

Related
3 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV Skin Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Wenyin Shi, MD, PhD

Thomas Jefferson University

Related
5 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV Melanoma
Similarity Score20%

Evanthia Galanis

Mayo Clinic

Related
2 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV Melanoma

Worked with same sponsors:

Mayo ClinicNational Cancer Institute (NCI)
Similarity Score20%

Jeffrey Weber

University of Southern California

Related
4 trials

Shared therapeutic areas:

Stage IV MelanomaRecurrent Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Cassian Yee

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
3 trials

Shared therapeutic areas:

Stage IV MelanomaRecurrent Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

David Solit

Memorial Sloan Kettering Cancer Center

Related
2 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Kevin Kim

M.D. Anderson Cancer Center

Related
3 trials

Shared therapeutic areas:

Stage IV MelanomaRecurrent Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT01789827Early Phase 1PrincipalInvestigator

Aldesleukin Imaging in Viewing Tumor Growth in Patients With Stage IV Melanoma Receiving Ipilimumab or Pembrolizumab Therapy

Stage IV Skin Melanoma
Completed
NCT00006243Not ApplicablePrincipalInvestigator

Vaccine Therapy and Sargramostim in Treating Patients With Stage IV Malignant Melanoma

Recurrent MelanomaStage IV Melanoma
Completed
NCT00024011Phase 2PrincipalInvestigator

PS-341 in Treating Patients With Metastatic Malignant Melanoma

Recurrent MelanomaStage IV Melanoma
Completed

All 3 trials loaded